Clinical Trials Logo

Filter by:
NCT ID: NCT05527678 Completed - Quality of Life Clinical Trials

5 Years Quality of Life and Early Mobilization in ICU

Promorea-qol
Start date: October 28, 2022
Phase:
Study type: Observational

In a study published in 2018 the research team had collected the Medical Research Council score (MRCs) at Intensive Care Unit (ICU) discharge. The investigators would like to be able to examine, if the preliminary results obtained by in 2020 by Van Aerde's team are confirmed in their cohort. The investigators hypothesize that patients with an MRCs less than or equal to 55 at discharge from the ICU, have a higher mortality rate than those with a score greater than 55. The investigators would also like to examine whether or not an MRCs score ≤ 55 is associated with a difference in quality of life and autonomy, after 5 and more years post ICU.

NCT ID: NCT05527626 Recruiting - Clinical trials for Chronic Kidney Diseases

Chronic Kidney Disease - REAL Life Study in Alsace

CKD-REAL
Start date: February 17, 2022
Phase:
Study type: Observational

Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry). Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage. Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.

NCT ID: NCT05527600 Completed - C23.888.592.612.081 Clinical Trials

Evaluation of an App Based on Artificial Intelligence for Pain Assessment in Pediatric Department

DEF II
Start date: March 7, 2023
Phase:
Study type: Observational

Accurate assessment of pain in Pediatric Department is challenging. However, recent publications highlight that children do not receive optimal pain management, particularly in Emergency Departments. An Artificial Intelligence-based tool could help physicians to optimize analgesia use.

NCT ID: NCT05527379 Completed - Anxiety Clinical Trials

Interest of Virtual Reality to Reduce Patient Anxiety During the Placement of a Percutaneous Implantable Port Catheter

RV-CIP
Start date: January 5, 2023
Phase: N/A
Study type: Interventional

The Vascular Access Unit (UAV) of the Lyon Sud Hospital Center is the first unit within a French public establishment where the Regional Health Agency (ARS) has authorized that medical procedures for the installation of central venous access be performed by nurses. The installation of CIP represents an anxiety-provoking step for the patient, because the gesture, which consists of inserting a box under the skin, connected to a catheter, placed in a deep vein, involves uncomfortable, even painful moments. In the UAV, the installation of this device is carried out in the operating room, without premedication and only under local anesthesia. Affected patients usually have a diagnosis of serious illness (oncology). Virtual Reality (VR) simulates the physical presence of the patient in an environment artificially generated by software. Many applications have already been evaluated in different health sectors, the investigators would like to show its interest in reducing patient anxiety during CIP placement under local anesthesia, without premedication. The medical device used is Lumeen. It is a Class I medical device software within the meaning of Regulation (EU) 2017/745, CE marked. In the context of research, the Relaxation module is used. This module is the one intended for the management of anxiety and pain induced by medical procedures in adults and children over 6 years of age. It allows to perform immersions in 360° videos in real shots or computer-generated images, accompanied by natural sounds, relaxing music and a relaxation script recorded by hypnotherapists. The duration of an immersion can be adjusted according to the needs of the medical procedure..

NCT ID: NCT05527132 Recruiting - Clinical trials for Aging of Breast Implants

Understanding the Phenomena of Aging and Rupture of Breast Implants

CRIMA
Start date: February 28, 2022
Phase:
Study type: Observational

Breast implants, like all implantable medical devices, are subject to wear and tear as they age in the body. In addition to this wear and tear, they are subject to external trauma, whether accidental during daily life, during insertion or during mammography. The kinetics and mechanisms of aging are poorly studied and the phenomenon of implant rupture is not elucidated. However, studies of older generation implants have shown that implant rupture is correlated with the duration of implantation.

NCT ID: NCT05527119 Completed - Plasmodium Vivax Clinical Trials

Phenotyping and Genotyping of Duffy Antigen

DARC
Start date: March 11, 2022
Phase:
Study type: Observational

Malaria remains the world's leading parasitic endemic. Almost half of the world's population lives in endemic areas. Many at-risk people in African countries remain without access to malaria control. Malaria kills approximately 400,000 people each year, most of whom are children under the age of 5 in Africa. Since 2005, an increasing number of Plasmodium vivax infections have been observed in Duffy-negative populations in South America and Africa, calling into question the essential role of the PvDBP-DARC interaction. The objective of the investigators is therefore to study and understand the invasion pathways used by Plasmodium vivax in Duffy-negative subjects.

NCT ID: NCT05526391 Recruiting - Clinical trials for Multiple System Atrophy

A Study of TAK-341 in Treatment of Multiple System Atrophy

Start date: November 9, 2022
Phase: Phase 2
Study type: Interventional

The main aim is to see how TAK-341 works after 52 weeks in participants with multiple system atrophy as measured by the Unified Multiple System Atrophy Rating Scale Part I (UMSARS). The study will enroll approximately 138 patients. Participants will receive a total of 13 intravenous infusions every 4 weeks approximately, these may be either of TAK-341 or placebo, after each infusion some blood samplings will be taken and other assessments completed. This trial will be conducted in North America, Europe and Asia.

NCT ID: NCT05525962 Recruiting - Child Development Clinical Trials

Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolescents in Child Welfare System.

EvolASE-PEA
Start date: September 29, 2022
Phase:
Study type: Observational

Assess the prevalence of medico-psychological characteristics at the time of placement (M0), their appearance / disappearance and during the two years following placement (M12 and M24) by age group in children / adolescents in Child Protective Services and placed full-time in the structures of Seine-Maritime and Eure as well as in nursery in Le Havre or Rouen

NCT ID: NCT05525741 Active, not recruiting - Clinical trials for Skin and Connective Tissue Diseases

Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients

MFC
Start date: October 19, 2022
Phase: N/A
Study type: Interventional

To compare the level of circulating functional mitochondria in the serum of vitiligo patients as compared to controls

NCT ID: NCT05525728 Recruiting - Dizziness; Syndrome Clinical Trials

Integrative Study of Vestibular Pathology

SENSORIEL2
Start date: June 18, 2022
Phase: N/A
Study type: Interventional

Exploratory posturological, neurosensory, cognitive, emotional, personality and general evaluations (quality of life). The investigators will characterize a sensory profile quantified by one or more scores from a multi-parameter baysian approach. Each parameter and these scores will be correlated to the type of vestibular damage and its recovery in order to establish diagnostic, prognostic and therapeutic follow-up markers.